Torrent Pharmaceuticals Ltd receives Form 483 from USFDA for Formulation Facility

Torrent Pharmaceuticals Ltd has announced that the United States Food & Drug Administration (USFDA) conducted a routine GMP inspection of our Formulation manufacturing facility located at Pithampur, Madhya Pradesh between 16-Sep-24 to 20-Sep-24.

At the end of the Inspection, the Agency issued a Form FDA 483 with one observation which is procedural in nature. We will respond to the USFDA within the prescribed time-frame and will work in close collaboration with the Agency to address the observation at the earliest possible time.

Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 3350.65 as compared to the previous close of Rs. 3360.35. The total number of shares traded during the day was 3162 in over 832 trades.

The stock hit an intraday high of Rs. 3395.85 and intraday low of 3321.35. The net turnover during the day was Rs. 10595701.00.

Source : Equity Bulls

Keywords

TorrentPharmaceuticals INE685A01028 FormulationManufacturingFacility USFDA GMPInspection Form483